Drug Profile
Botulinum toxin - OBI Pharma
Alternative Names: OBI 858Latest Information Update: 15 Dec 2021
Price :
$50
*
At a glance
- Originator OBI Pharma
- Class Antispasmodics; Bacterial proteins; Bacterial toxins; Muscle relaxants; Urologics
- Mechanism of Action Acetylcholine inhibitors; Glutamate antagonists; Neuromuscular blocking agents
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Migraine
Most Recent Events
- 28 Aug 2021 No recent reports of development identified for preclinical development in Migraine in Taiwan (Parenteral)
- 14 Jul 2017 Preclinical trials in Migraine in Taiwan (Parenteral) (OBI Pharma pipeline, July 2017)